<p>*: p values were 0.386, 0.663, 0.865 across different WHO regions and 0.008, 0.008, 0.018 across different income levels for the number of essential medicines for diabetes, number of “Insulin and analogues” and number of “Oral blood glucose lowering” medicines, respectively.</p><p>Number of selected essential medicines for diabetes on NEMLs in different geographical regions and across different income levels.</p
<p>Association between gross domestic product (GDP) per capita and the total number of essential dia...
Background: One third of the world population does not have access to essential medicines. Diabetes...
Approximately 80% of the 463 million adults worldwide with diabetes live in low- and middle-income c...
Aim: Diabetes is a growing burden especially in low and middle income countries (LMICs). Inadequate ...
AIM: Diabetes is a growing burden especially in low and middle income countries (LMICs). Inadequate ...
AIM: Diabetes is a growing burden especially in low and middle income countries (LMICs). Inadequate ...
AIM: Diabetes is a growing burden especially in low and middle income countries (LMICs). Inadequate ...
<p>Association between relative burden of diabetes in countries and the total number of essential di...
Number of NCD medicines with available data on consumption and prices, by disease category and count...
<p>Inclusion of diabetes medications in the NEMLs of low and middle income countries (n = 32).</p
<p>ACE angiotensin converting enzyme, Angiotensin II receptor blockers, N number of participants.</p...
<p>DM = diabetes mellitus, N = number of participants, NGT = normal glucose tolerance, undef = u...
BACKGROUND: Data are scarce on the availability and affordability of essential medicines for diabete...
<p>N number of participants.</p>a<p>p≤0.05 for urban vs. rural difference.</p>b<p>p≤0.05 for age.</p...
The global diabetes cascade of care in population-based surveys conducted in 28 low- and middle-inco...
<p>Association between gross domestic product (GDP) per capita and the total number of essential dia...
Background: One third of the world population does not have access to essential medicines. Diabetes...
Approximately 80% of the 463 million adults worldwide with diabetes live in low- and middle-income c...
Aim: Diabetes is a growing burden especially in low and middle income countries (LMICs). Inadequate ...
AIM: Diabetes is a growing burden especially in low and middle income countries (LMICs). Inadequate ...
AIM: Diabetes is a growing burden especially in low and middle income countries (LMICs). Inadequate ...
AIM: Diabetes is a growing burden especially in low and middle income countries (LMICs). Inadequate ...
<p>Association between relative burden of diabetes in countries and the total number of essential di...
Number of NCD medicines with available data on consumption and prices, by disease category and count...
<p>Inclusion of diabetes medications in the NEMLs of low and middle income countries (n = 32).</p
<p>ACE angiotensin converting enzyme, Angiotensin II receptor blockers, N number of participants.</p...
<p>DM = diabetes mellitus, N = number of participants, NGT = normal glucose tolerance, undef = u...
BACKGROUND: Data are scarce on the availability and affordability of essential medicines for diabete...
<p>N number of participants.</p>a<p>p≤0.05 for urban vs. rural difference.</p>b<p>p≤0.05 for age.</p...
The global diabetes cascade of care in population-based surveys conducted in 28 low- and middle-inco...
<p>Association between gross domestic product (GDP) per capita and the total number of essential dia...
Background: One third of the world population does not have access to essential medicines. Diabetes...
Approximately 80% of the 463 million adults worldwide with diabetes live in low- and middle-income c...